Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer

European Surgical Research

Volumn 39, Issue 4, 2007, Pages 245-250

  Wang, J Y ^a,b   Lu, C Y ^a   Chu, K S ^a,b   Ma, C J ^a   Wu, D C ^a,b   Tsai, H L ^a   Yu, F J ^a   Hsieh, J S ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Carcinoembryonic antigen; Colorectal cancer; Colorectal cancer, prognosis; Postoperative surveillance

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANALYTICAL PARAMETERS; ANTIGEN DETECTION; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEMOCONCENTRATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SURVIVAL RATE;

AGED; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 34347214447     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101952     Document Type: Article

References (18)

1. Macdonald JS: Adjuvant therapy of colorectal cancer. CA Cancer J Clin 1999;49:202-219.
2. International Union Against Cancer: TNM classification of malignant tumors, ed 6. New York, Wiley-Liss, 2002.
3. Klee GG, Go VJW: Carcinoembryonic antigen and its role in clinical practice; in Ghosh BC, Ghosh L (eds): Tumor Markers and Tumor-Associated Antigens. New York, McGraw-Hill, 1990, pp 22-43.
4. Gold P, Freedman SO: Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965;122:467-481.
5. Wanebo HJ, Rao B, Pinsky CM: The use of preoperative carcinoembryonic antigen level as a prognostic indicator to complement pathological staging. N Engl J Med 1978;299:448-451.
6. Chu D, Erickson CA, Russell P, Thompson C, Lang NP, Broadwater RJ, Westbrook KC: Prognostic significance of carcinoembryonic antigen in colorectal cancer. Arch Surg 1991;125:314-316.
7. Harrison LE, Guillem JG, Paty P, Cohen AM: Preoperative carcinoembryonic antigen predicts outcome in node negative colon cancer patients: a multivariate analysis of 572 patients. J Am Coll Surg 1997;1185:55-59.
8. Watine J, Miedouge M, Friedberg B: Carcinoembryonic antigen as an independent prognostic factor of recurrence and survival in patients resected for colorectal liver metastases: a systematic review. Dis Colon Rectum 2001;44:1791-1799.
9. Wiratkapun S, Kraemer M, Seow-Choen F, Ho YH, Eu KW: High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: results of a five-year study. Dis Colon Rectum 2001;44:231-235.
10. McCall JL, Black RB, Rich CA, Harvey JR, Baker RA, Watts JM, Toouli J: The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994;37:875-881.
11. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP: American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 2000;88:1739-1757.
12. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C: Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:979-994.
13. Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, Nilsson O, Sturgeon C, Topolcan O: Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 2003;39:718-727.
14. Guadagni F, Roselli M, Cosimelli M, Spila A, Cavaliere F, Arcuri R, D'Alessandro R, Fracasso PL, Casale V, Vecchione A, Casciani CU, Greiner JW, Schlom J: Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlation. Int J Cancer 1997;72:949-954.
15. Forslund A, Engarås B, Lönnroth C, Lundholm K: Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA50, CA242 and conventional blood tests in patients with colorectal carcinoma. Int J Oncol 2000;20:1013-1018.
16. Louhimo J, Carpelan-Holmstrom M, Alfthan H, Stenman UH, Jarvinen HJ, Haglund C: Serum HCG-β, CA72-4 and CEA are independent prognostic factors in colorectal cancer. Int J Cancer 2002;101:545-548.
17. Slentz K, Senagore A, Hibbert J, Mazier WP, Talbott TM: Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg 1994;60:528-531.
18. Chen CC, Yang SH, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Chang SC: Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? J Surg Res 2005;124:169-174.